OBJECTIVE: The autopsy and clinical information on children dying with anti-SSA/Ro-associated cardiac manifestations of neonatal lupus (cardiac NL) were examined to identify patterns of disease, gain insight into pathogenesis and enhance the search for biomarkers and preventive therapies. METHODS: A retrospective analysis evaluating reports from 18 autopsies of cardiac NL cases and clinical data from the Research Registry for Neonatal Lupus was performed. RESULTS: Of the 18 cases with autopsies, 15 had advanced heart block, including 3 who died in the second trimester, 9 in the third trimester and 3 post-natally. Three others died of cardiomyopathy without advanced block, including two dying pre-natally and one after birth. Pathological findings included fibrosis/calcification of the atrioventricular (AV) node, sinoatrial (SA) node and bundle of His, endocardial fibroelastosis (EFE), papillary muscle fibrosis, valvular disease, calcification of the atrial septum and mononuclear pancarditis. There was no association of pathology with the timing of death except that in the third-trimester deaths more valvular disease and/or extensive conduction system abnormalities were observed. Clinical rhythm did not always correlate with pathology of the conduction system, and the pre-mortem echocardiograms did not consistently detect the extent of pathology. CONCLUSION: Fibrosis of the AV node/distal conduction system is the most characteristic histopathological finding. Fibrosis of the SA node and bundle of His, EFE and valve damage are also part of the anti-Ro spectrum of injury. Discordance between echocardiograms and pathology findings should prompt the search for more sensitive methods to accurately study the phenotype of antibody damage.
OBJECTIVE: The autopsy and clinical information on children dying with anti-SSA/Ro-associated cardiac manifestations of neonatal lupus (cardiac NL) were examined to identify patterns of disease, gain insight into pathogenesis and enhance the search for biomarkers and preventive therapies. METHODS: A retrospective analysis evaluating reports from 18 autopsies of cardiac NL cases and clinical data from the Research Registry for Neonatal Lupus was performed. RESULTS: Of the 18 cases with autopsies, 15 had advanced heart block, including 3 who died in the second trimester, 9 in the third trimester and 3 post-natally. Three others died of cardiomyopathy without advanced block, including two dying pre-natally and one after birth. Pathological findings included fibrosis/calcification of the atrioventricular (AV) node, sinoatrial (SA) node and bundle of His, endocardial fibroelastosis (EFE), papillary muscle fibrosis, valvular disease, calcification of the atrial septum and mononuclear pancarditis. There was no association of pathology with the timing of death except that in the third-trimester deaths more valvular disease and/or extensive conduction system abnormalities were observed. Clinical rhythm did not always correlate with pathology of the conduction system, and the pre-mortem echocardiograms did not consistently detect the extent of pathology. CONCLUSION:Fibrosis of the AV node/distal conduction system is the most characteristic histopathological finding. Fibrosis of the SA node and bundle of His, EFE and valve damage are also part of the anti-Ro spectrum of injury. Discordance between echocardiograms and pathology findings should prompt the search for more sensitive methods to accurately study the phenotype of antibody damage.
Authors: Robert M Clancy; Jill P Buyon; Keigo Ikeda; Kazuhisa Nozawa; Dionne A Argyle; Deborah M Friedman; Edward K L Chan Journal: Arthritis Rheum Date: 2005-10
Authors: Robert M Clancy; Petra J Neufing; Ping Zheng; Marguerita O'Mahony; Falk Nimmerjahn; Tom P Gordon; Jill P Buyon Journal: J Clin Invest Date: 2006-08-10 Impact factor: 14.808
Authors: Carolina Llanos; Edward K L Chan; Songqing Li; Grant X Abadal; Peter Izmirly; Caroline Byrne; Robert M Clancy; Jill P Buyon Journal: J Rheumatol Date: 2009-02-04 Impact factor: 4.666
Authors: T L Rivera; P M Izmirly; B K Birnbaum; P Byrne; J B Brauth; M Katholi; M Y Kim; J Fischer; R M Clancy; J P Buyon Journal: Ann Rheum Dis Date: 2008-07-14 Impact factor: 19.103
Authors: Deborah M Friedman; Mimi Y Kim; Joshua A Copel; Claudine Davis; Colin K L Phoon; Julie S Glickstein; Jill P Buyon Journal: Circulation Date: 2008-01-14 Impact factor: 29.690
Authors: Carolina Llanos; Peter M Izmirly; Margaret Katholi; Robert M Clancy; Deborah M Friedman; Mimi Y Kim; Jill P Buyon Journal: Arthritis Rheum Date: 2009-10
Authors: Robert M Clancy; Marc Halushka; Sara E Rasmussen; Tenzin Lhakhang; Miao Chang; Jill P Buyon Journal: J Immunol Date: 2018-12-05 Impact factor: 5.422
Authors: Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon Journal: J Am Coll Cardiol Date: 2015-08-25 Impact factor: 24.094
Authors: Robert M Clancy; Androo J Markham; Tanisha Jackson; Sara E Rasmussen; Miroslav Blumenberg; Jill P Buyon Journal: Am J Physiol Heart Circ Physiol Date: 2017-06-16 Impact factor: 4.733
Authors: Robert M Clancy; Androo J Markham; Joanne H Reed; Miroslav Blumenberg; Marc K Halushka; Jill P Buyon Journal: J Autoimmun Date: 2015-10-01 Impact factor: 7.094
Authors: Deborah Friedman; Leif Lovig; Marc Halushka; Robert M Clancy; Peter M Izmirly; Jill P Buyon Journal: Clin Exp Rheumatol Date: 2017-06-06 Impact factor: 4.473
Authors: Hannah C Ainsworth; Miranda C Marion; Tiziana Bertero; Antonio Brucato; Rolando Cimaz; Nathalie Costedoat-Chalumeau; Micaela Fredi; Patrick Gaffney; Jennifer Kelly; Kateri Levesque; Alice Maltret; Nathalie Morel; Veronique Ramoni; Amelia Ruffatti; Carl D Langefeld; Jill P Buyon; Robert M Clancy Journal: Arthritis Rheumatol Date: 2017-10-17 Impact factor: 10.995
Authors: Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta Journal: Nat Rev Rheumatol Date: 2015-03-24 Impact factor: 20.543
Authors: Paraskevi Briassouli; Marc K Halushka; Joanne H Reed; Yair Molad; Karen Fox-Talbot; Lucas Buyon; Edwin Guzman; Achiau Ludomirsky; Robert M Clancy; Jill P Buyon Journal: Rheumatology (Oxford) Date: 2013-04-18 Impact factor: 7.580
Authors: Peter Izmirly; Mimi Kim; Deborah M Friedman; Nathalie Costedoat-Chalumeau; Robert Clancy; Joshua A Copel; Colin K L Phoon; Bettina F Cuneo; Rebecca E Cohen; Kimberly Robins; Mala Masson; Benjamin J Wainwright; Noel Zahr; Amit Saxena; Jill P Buyon Journal: J Am Coll Cardiol Date: 2020-07-21 Impact factor: 24.094